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Achondroplasia, Duchenne muscular dystrophy, and osteogenesis imperfecta are among the most frequent rare
genetic disorders affecting the musculoskeletal system in children. Rare genetic disorders are severely disabling and
can have substantial impacts on families, children, and on healthcare systems. This literature review aims to classify,
summarize and compare these non-medical impacts of achondroplasia, Duchenne muscular dystrophy and
osteogenesis imperfecta.
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L’achondroplasie, la dystrophie musculaire de Duchenne et l’ostéogenèse imparfaite sont des maladies génétiques
rares du système musculo-squelettique pédiatrique. On assiste à un intérêt croissant pour l’étude des maladies
génétiques rares dont la plupart sont handicapantes et ont des conséquences néfastes sur familles, les patients et
les systèmes de santé. Malgré leurs spécificités, certaines conséquences des maladies génétiques rares sont communes
et gagneraient à être étudiées de façon générique. Cependant, plusieurs travaux continuent d’adopter une approche
spécifique à une maladie. Par ailleurs, on assiste à un foisonnement de termes qui évaluent les conséquences des
maladies génétiques rares (qualité de vie, impact, effet, fardeau etc.…). Si ce pléthore de termes reflète la complexité
du sujet, il rend difficile la synthèse et la comparaison entre maladies. Dans cet article, les auteurs classifient puis effectuent
une revue narrative et comparative des impacts de trois maladies génétiques musculo-squelettiques pédiatriques:
l’achondroplasie, la dystrophie musculaire de Duchenne et l’ostéogenèse imparfaite.Introduction
A rare disease is defined as one that affects less than one in
2000 individuals in Europe and one in 1250 in the United
States [1]. Most rare diseases are severely disabling gen-
etic disorders that can have substantial impacts on fam-
ilies and children, and on healthcare systems [2,3].* Correspondence: joyce-maman.dogba@fmed.ulaval.ca
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unless otherwise stated.Despite their specific biomedical features, many rare genetic
diseases (RGDs) share several non-medical characteristics,
in particular, their psychosocial consequences [4]. While it
is acknowledged that research on these non-medical com-
mon features may benefit from a non-categorical ap-
proach, a disease-specific approach remains common. In
addition, the literature assessing these issues is sometimes
difficult to summarize due to the inconsistent use of ter-
minology. Several terms are commonly used in the litera-
ture to examine the impacts of RGDs: burden of care,
quality of life, impacts, consequences, meaning of leaving,
and coping strategies [5-7]. This proliferation of concepts,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ition (e.g., biomedical, psychological, economic, social and
nursing) reflects the complexity of the field, but may also
lead to a fragmented version of ‘the same reality’. A clear
and synthetized conceptualization of the impacts of RGDs
with a non-disease-specific approach is warranted. Scop-
ing reviews, an increasingly popular knowledge synthesis
approach in health care, can help in such conceptualization
[8]. Moreover, scoping reviews can yield a framework for
collating and summarizing results that can empower pa-
tients and families, raise awareness among health care
professionals, identify knowledge gaps and priorities for
future research, and advocate for policies to develop sup-
port services for families [8,9].
This paper reports a scoping review that describes the
literature on non-medical impacts for patients and fam-
ilies. Due to the exploratory nature of the review and to
reflect the research areas of our team, we delineated the
focus of this review to three common RGDs in the
pediatric orthopedic context: achondroplasia, Duchenne
muscular dystrophy (DMD) and osteogenesis imperfecta
(OI). These three RGDs are single-gene musculoskeletal
diseases characterized by physical disability and little or
no impairment of mental ability. Table 1 provides their
clinical and genetic characteristics.
The three specific objectives of this review research
were: i) to categorize the types of non-medical impacts
of achondroplasia, DMD and OI; ii) to summarize
these impacts; and iii) to discuss findings on these im-
pacts across the three diseases.
Methods
While systematic reviews synthesize the complete nature
of a particular field, outlining what approaches are effectiveTable 1 Key features of achondroplasia, DMD and OI
Disease, features Achondroplasia Duchenne musc
Orphanet number and
synonyms
ORPHA 15 ORPHA 98896
Prevalence 4/100,000 30/100,000 males
Genetic defect Change in the DNA for fibroblast
growth factor receptor 3 (FGFR3),
which causes an abnormality
of cartilage formation
Absence of the p
skeletal muscle, m
Mode of transmission Autosomal dominant X-linked recessive
Clinical symptoms Short stature Progressive weakn
deformity, restricti
and cardiomyopat
Cognitive impairment None noted Some variable de
involvement
Diagnosis Neonatal; Prenatal in USA Childhood
Lifespan Unimpaired Death in early adand where further research is required, scoping reviews
are exploratory projects that map the literature available
on a topic, identifying the key concepts, theories, sources
of evidence, and gaps in the research [10]. We therefore
opted for a scoping review to allow for a quick mapping of
the “key concepts underpinning a research area and the
main sources and types of evidence available” [11]. We
adopted a broad definition of impact that includes conse-
quences of, but also reactions to, a disease. We followed
the five stages suggested for a quality scoping review:
i) identification of the research question; ii) identifi-
cation of relevant studies; iii) selection of studies to
include in the review; iv) charting of information and
data within the included studies; and v) collating, sum-
marizing and reporting results of the review [11].
Identification of relevant publications
From March to June, 2013, we conducted a search of the
literature in three electronic databases: Web of Science,
CINAHL, and MEDLINE. The following two string com-
binations of keywords were used: [Impact, burden, quality
of life, living with, coping, adjustment, well-being, quality
of life, effects, impacts, responses, reactions, psychosocial]
AND [Rare genetic disease/disorder, rare childhood
disease, osteogenesis imperfecta, brittle bone disease,
Duchenne muscular dystrophy, achondroplasia, chronic
illness, musculoskeletal system, physical disorders]. We
complemented our search for publications with a system-
atic screening of the table of contents of specific journals
dedicated to rare diseases (e.g. Orphanet Journal of Rare
Diseases) and a screening of references of relevant publi-
cations. Opinions, commentaries, letters, editorials, and
publications without an abstract were immediately initially





Mutation in gene encoding collagen type I;
deficiencies in proteins that interact with collagen
(CRTAP, P3H1, PPIB, Serpin H1 and FKBP10)
Primarily autosomal dominant, although
recessive cases reported
ess, contractures, spinal
ve lung functional pattern,
hy
Increased bone fragility; fractures
gree of cognitive None noted
Variable
ulthood Variable (unimpaired in types I, and IV), possibly
somewhat decreased in type III) [81]
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independently selected publications addressing the non-
medical impacts of Achondroplasia, DMD and OI, based
on the titles and the abstracts. Publications that addressed
a rare genetic disease other than the three retained by the
research group were excluded from this review, as were
publications focussed on the identification of genes. In the
case of disagreement among authors, the full-text publica-
tions were reviewed by a third senior author. A total of 65
full-text publications remained at this stage of the review.
Selection of studies to include in the review
For inclusion in our study, publications had to be i) pub-
lished between 1980 and 2013; ii) in English or French;
iii) about non-medical effects and responses to OI,
achondroplasia and DMD; and iv) have a well-defined
methodology. Because a scoping review is not intended
to assess the quality of studies, emphasis was not placed
on methodological rigor of the retained studies. At this
second stage, 8 publications were excluded as they ex-
amined medical impacts of a treatment or intervention,
and 57 publications were retained. Figure 1 displays the
study selection flow diagram. We used a data extractionFigure 1 Study selection flow diagram.grid to gather the following items: i) general information
(e.g., type of study, country, focus); and ii) the relevance
of the article to our study and the scientific information
such as concepts, theoretical orientation, methodology,
and research tradition.
Collating, summarizing and reporting results of the
review
The 57 retained publications were coded using qualitative
structure coding [12] with Nvivo 10 (QSR International)
and Endnote X6. From this, we identified main study
themes and grouped based on similarity. We iteratively
constructed a working framework (Figure 2) to examine
separately the extent, range and research activity for OI,
achondroplasia and DMD. The adequacy of the frame-
work to review question was tested independently by two
authors (MJD and ED) on 10 selected articles. Disagree-
ments were solved by discussion among these authors or
by the adjudication of a senior author (FR).
To ensure consistent mapping and analysis of data, we
developed a glossary of codes used to classify the im-
pacts as follows: i) ‘scope’ refers to whether the article
addresses one or several pediatric rare musculoskeletal
Figure 2 Framework redefining impacts of rare genetic diseases.
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article studied the ‘Effect of Disease’ (Direction 1) or
‘Response to the Disease’ (Direction 2); iii) ‘target’ refers
to three distinct groups of focus: ‘individuals’ such as pa-
tients, adults, carers, or siblings; ‘groups’ such as physi-
cians, caregivers, or school teachers; and ‘societies’ such
as communities or society as a whole; iv) ‘timeline’ and
‘trend’ refer to the temporal analysis of impacts; and v)
‘type’ refers to positive or negative consequences; finally
vi) ‘domain’ refers to the aspect of QOL being studied
(psychological, functional and so on) or the research
tradition or academic discipline used to study the im-
pacts. Once the 57 publications were categorized, we
performed a narrative review of the findings on the im-
pacts separately for each disease, and then critically
compared the findings across the three diseases. An
overview of the distribution of the publications using thecomponents of our working framework is presented, as
well as a summary of the major findings of the publica-
tions achondroplasia, DMD and OI. Finally, we discuss
how research compares across the three diseases.
Results
A total of 57 publications on non-medical impacts are in-
cluded in this review study: 3 about achondroplasia [13-15],
39 about DMD [16-54] and 15 about OI [55-69].
Overview of the publications
The majority of the publications (50) were original re-
search focused on a single disease, while 6 publications
concerned two diseases (DMD and other diseases), and
1 publication was a literature review.
The target group assessed was spread between the
experiences of the individual with the disease (26), the
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caregivers only (8), or were focused on the impacts of other
groups or tool development and reviews of the literature
(5; physicians’ attitudes, the effects on community).
The direction of the impacts was explicitly stated in 44
of the 57: 31 addressed the effects and impacts of living
with achondroplasia, DMD or OI, 13 addressed responses
to living with the disease on individuals, groups or society
(such as resilience, adjustment, coping strategies and atti-
tudes). In these 44 papers, the occurrence of a RGD was
conceptualised as a source of stress to which people react.
The direction was either a combination of directions, or
not explicitly stated, in the remaining 13 papers. Table 2
outlines the studies according to the scope, target, direc-
tion, timeline, trend, and type of impacts.
Papers were also spread over several domains (as defined
above), with 15 examining the quality of life (QOL)
through a normative and validated measure of function,
psychosocial well-being, and perception of health (2 achon-
droplasia, 7 DMD, and 6 OI). Psychosocial impacts on their
own were addressed in 18 publications (14 DMD, 4 OI),
and functional status on its own was addressed in 10 publi-
cations (1 achondroplasia, 6 DMD, 3 OI). The remaining
14 publications assessed the domains of illness experience,
utilisation of healthcare services, palliative care, medical
staff reactions to the disease, or newborn screening.
Tables 3, 4 and 5 report the general information and
major findings of the publications for the domain.
Narrative review
The non-medical impacts of achondroplasia
Evidence from the publications on achondroplasia sug-
gests that affected individuals have an impaired QOL
when compared to first-degree relatives [14]. The lower
QOL could mainly be linked to psychosocial limitations
including lower self-esteem and social stigmatization, to
the extent that serial lower limb lengthening appeared a
good option to patients despite its numerous complica-
tions [13,15]. The functional status of patients with achon-
droplasia was impaired by back pain and pain in the lower
extremity, resulting in some cases in complete cessation
of work. However, the functional limitation and psycho-
logical distress remained unchanged over time [13].
The non-medical impacts of DMD
The overall QOL of parents and their children who are
affected with DMD was reported to be lower than in the
general population, particularly due to impairments in
physical functioning [19,42]. Boys with DMD reported
significantly lower QOL than healthy peers in physical
and psychosocial domains. Physical limitations increased
with age as respiratory problems and muscle weaknesses
occurred. However, despite the progressive course of the
disease, the psychosocial QOL tended to be higher inadolescents with DMD than in their younger counter-
parts, suggesting the development of effective coping
strategies over time [41,50,52]. For parents, the psycho-
social impacts were reported to be great, and quality of
life decreased even more around the period of patient
transition to wheelchair [22,23]. Finally, parental reports
of QOL did not consistently match that of their children,
with many underestimating their child’s QOL [23].
The 14 studies that solely examined the psychological
impacts of DMD reported higher levels of anxiety, de-
pression, and guilt in parents, particularly in mothers
[25,26,46]. However, early diagnosis and family hardiness
(the energy resources of the family such as commitment,
challenge, and control) were reported to positively in-
fluence parental psychological adjustments, the pa-
tients’ level of resilience and the reactions of siblings
[20,24,26,29,34,43,48,49,51,53].
In addition to the psychological impacts, parents, par-
ticularly mothers, reported caring for their children with
DMD to be burdensome (help for bathing, toileting),
costly in terms of time, and contributing to increased social
isolation [44]. Altogether, participation in daily activities
and social life was reduced for patients. Siblings of adoles-
cents with DMD seemed more negatively affected than
siblings of healthier counterparts.
The non-medical impacts of OI
There was little difference in the overall QOL of those
diagnosed with OI as compared to the general population.
Functional limitations were more important in patients
with severe forms of OI, and higher life satisfaction, resili-
ence, low depression and higher social achievements were
common [55,64,68]. Parents reported several accusations
of child abuse, lack of information on the disease, disrup-
tions of family activities due to the occurrence of fractures,
and social isolation [56-58].
Other findings
Besides these psychosocial impacts of achondroplasia,
DMD and OI on families, the impacts on groups and the
society were broached in few studies. Two publications
examined the attitudes of medical staff about a condition
or related treatments options [17,40]. These publications
concluded that physicians could promote some experimen-
tal treatment options provided that there was a shared-
decision making with families. The medical staffs were also
found to support newborn and prenatal screening when-
ever available. Finally, it should be noted that the impacts
on the use of health services and economic factors were
not assessed in the papers included in this review.
Discussion
The impacts of achondroplasia, DMD and OI on fam-
ilies reported in this review are derived from in-depth
Table 2 Overview of the publications according to diseases, scope, target and directions of the impacts
Disease Scope of the impacts Target of the impacts Directions of the impacts
One disease Multiple diseases Patients only Carers only Families Other
groups/society





3, [13-15] 0 2, [13,15] 0 1, [14] 0 2, [13,15] 1, [14] 0
DMD, (N =39) 33, [16,18-20,
22-34,38,40-54]
6, [17,21,35-37,39] 15, [20,21,23,29,33,34,
41,43,45,47,50,51,53,54]
7, [16,24,26,27,36,39,44] 12, [18,19,23,25,28,
31,32,35,46,48,49,52]

























Table 3 Summary of findings of publications on non-medical impacts of achondroplasia
Publication Major findings Domain Instruments used Sample (N) Country
Gollust, Thompson et al. [14] This index measures mean total QOL
and indicates higher QOL. Respondents
judge their satisfaction with 34 distinct
life domains and judge how important
each is to their life, producing QOL
scores that reflect respondents’ values.







Kim, Balce et al. [15] The physical and functional scores of
patients who had surgery were equivalent
to those of the nonsurgical group. Even
with numerous complications, our data
show serial lower limb lengthening is a
good option for patients with
achondroplasia in terms of good QOL
scores. The patients who had surgery for
lengthening scored well in the mental
component of the SF-36 and in the
Rosenberg self-esteem questionnaire.
QOL American Academy of
Orthopaedic Surgeons
(AAOS) lower limb, SF-36,
Rosenberg self-esteem
scores
22 patients who had
bilateral leg lengthening,
22 patients who did not
Korea
Ain, Abdullah et al. [13] Back pain associated with proximal and/or
distal leg pain was associated with higher
functional disability, more psychological
distress, and more physical symptoms.
Increase in healthcare use and increase
in the number of individuals who had
stopped working or changed their type











181 affected adults USA
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objective normative measures of QOL. These methodo-
logical specificities resulted in variations in the impacts
between and within similar categories of publications
that may limit the comparison across the three diseases.
However, caring for children particularly with DMD and
OI was burdensome because of daily practical problems
(bathing, toileting), increased time costs and social isola-
tion, as reported in studies on other RGDs [70-72]. Con-
sequently, carers reported lower QOL particularly in
critical periods of loss of ambulation in boys with DMD
and during the occurrence of fractures in OI as recently
confirmed [73].
As for the QOL in patients with these three diseases,
findings seem contradictory with some publications
reporting higher QOL and other reporting lower QOL
when compared to healthier unaffected controls [20,22].
The severity of functional and physical impairments fol-
low the severity of the disease, and could be seen as in-
creasing from small functional impairment, such as back
pain in achondroplasia, to restricted ambulation from
bone deformities and numerous fractures in OI, to pro-
gressively reduced ambulation and confinement to a
wheelchair in DMD [22]. On the contrary and strikingly,
the psychological aspect of QOL in patients did not parallel
the severity of the disease. For example, DMD is life-
threatening and its psychosocial impacts are expected to be
more severe than for achondroplasia and OI; however, pa-
tients with OI did not seem to experience less psychologicaldistress than those with DMD [41,69]. As for the course
of the disease, the stable (unchanged) level of psycho-
logical distress in patients with achondroplasia reflects the
non-progressive course of the disease [13]. The “up and
down” pattern of psychological distress in patients with
severe OI also confirms the occurrence of fractures as crit-
ical periods over the chronic course of OI [73]. While
functional limitations increased, the self-reported psycho-
social QOL of boys with DMD did not decrease with age.
They may have developed effective coping strategies that
ought to have been better documented [52]. This finding
was confirmed in previous studies. Indeed the level of im-
pact on family including psychological stress was high for
families who had children affected by rare genetic meta-
bolic conditions even when the child’s function was not
impaired and the disease was not severe [5].
Some practical implications emerged from this review
that can benefit families and caregivers. The correlation
between improved parental coping strategies and early
diagnosis, better emotional functioning of the child and
siblings suggests that there have been efforts to obtain-
ing an early diagnosis and promoting family hardiness
for people living with these diseases [74,75]. To that end,
interprofessional teams of geneticists, psychologists and
social workers in reference centers for these rare diseases
could be effective by offering newborn screening, family-
centered and life-span psychosocial support whenever
possible [76]. Besides, informal support from family
and friends but also institutional health and social support
Table 4 Summary of the findings of publications on non-medical impacts of DMD
Publication Major findings Domain Instruments used Sample (N) Country
Baiardini, Minetti et al. [19] Using the Children's Health Questionnaire, children with DMD
were significantly limited in performing physical activities and
demonstrated difficulties with school and other daily activities.
The family dynamic appeared to remain intact, but some
parents and caregivers reported problems with social aspects
of their life.
QOL Children Health Questionnaire-Parent





Bray, Bundy et al. [22] Parents of boys with DMD reported significantly poorer health
and physical functioning than healthy controls. Parents reported
that transitioning to a wheelchair was a particularly difficult time.




Bray, Bundy et al. [23] Boys with DMB reported significantly lower health-related
quality of life compared to the general population, with a
moderate to poor correlation with reports from their parents,
with parents generally underestimating quality of life
of their sons.






Uzark, King et al. [52] QOL scores for boys with DMD were significantly lower than
those for healthy children for physical and psychosocial QOL.
Psychosocial QOL scores were highly impaired particularly in
older patients and not significantly associated with use of
mobility aids.





Kohler, Clarenbach et al. [41] Patients with DMD reported a high level of perceived quality
of life. Despite severe limitations in physical functioning,
patients reported less role limitations, physical and mental
problems, and coping abilities.
QOL Medical Outcome Questionnaire




Manzur, Kinali et al. [42] There have been improvements in general care and treatment
modalities for patients with DMD, with survival into adulthood
now a possibility. Multidisciplinary and holistic treatment
approaches are also recommended. Curative therapeutic
strategies such as cell and gene therapy are currently
experimental.
QOL N/A – Literature Review N/A UK
Simon, Resende et al. [50] Comparing different age groups, patients with DMD did not
lose QOL, even with disease progression. In spite of the
progressive course of the disease, the QOL in patients
with DMD does not worsen.





Garralda, Muntoni et al. [32] Parents with children with KAFOS reported satisfaction with
the rehabilitation process, but some expressed a desire to
have had more information beforehand. Families of
children with more severe disability reported higher levels
of mental distress during the process.
Functional
limitations






Bendixen, Senesac et al. [20] When compared with unaffected controls, boys with DMD
displayed significantly lower participation in both physical
and social activities. Boys with DMD also demonstrated





Disability Inventory (FDI), The Strengths
and Difficulties Questionnaires (SDQ),
General Health Questionnaire (GHQ-28),
Impact of Events Scale (IES)























Table 4 Summary of the findings of publications on non-medical impacts of DMD (Continued)
Hanayama, Liu et al. [33] For patients with DMD, commonly observed symptoms
associated with dysphagia included oral residuals,
coughing while eating, choking while eating, and the need
to clear the throat. This demonstrated that a significant
portion of patients with DMD had swallowing-related
symptoms into their teenage years.
Functional
limitations
Children’s Assessment of Participation
and Enjoyment, Pediatric Quality of




Marini, Lorusso et al. [43] The DMD group demonstrated reduced abilities in language
processing and cognition, specifically visual attention, but
not in receptive or expressive lexical abilities. As well, the
narrative speech in subjects with DMD was reduced
compared to controls, with shorter sentences.
Functional
limitations
Survey of swallowing related






van Wijk, Messelink et al. [53] Lower urinary tract symptoms in DMD patients are
underreported and underdiagnosed; however, the vast
majority of male DMD patients with symptoms experience
them as a problem, often reducing quality of life.
Functional
limitations
Assessment of narrative abilities




Read, Kinali et al. [48] Unaffected siblings demonstrated comparative psychological
functioning and wellbeing scores; however, there was a
trend towards increased risk for psychological and
emotional problems. Siblings also reported a high impact
of their affected sibling's illness on their lives.
Psychological
impacts
Strengths and Difficulties Questionnaire
(SDQ), General Health Questionnaire
(GHQ), Hospital Anxiety and Depression
Scale (HADS), SF-36, Functional
Disability Inventory (FDI), Family
Assessment Device (FAD), Family






Read, Kinali et al. [49] Siblings reported feeling left out when the affected sibling











Kenneson and Bobo [39] About half of the caregivers experienced a high level of
caregiving demand based on the abbreviated four-item ZBI,
consistent with previous report using the full ZBI scale.
Psychological
impacts
Survey, components from: Johnson &
Johnson Stress Profile, Kessler (K6),
Behavioral Risk Factor Surveillance
System (BRFSS), Zarit Burden
Interview (ZBI), Brief Resilient Coping







James, Hadley et al. [35] Guilt in parents of those with disabilities is associated with
depression, helplessness, hopelessness, and disruption of
effective parenting. Maternal guilt appears common in
XL conditions. Understanding reproductive risks had no
significant impact on level of worry among all family
members implies that, at least for fathers, siblings, and
affected adults, worry is related less to empiric risks and
understanding of those risks than to the experience of
having an affected family member.
Psychological
impacts
Questionnaire developed by authors 112 members of





Hendriksen, Poysky et al. [34] The results demonstrate the PARS-III is a reliable and
valid measure for screening psychosocial adjustment
for individuals with DMD. As well, older patients
demonstrated higher overall psychosocial adjustment.
Psychological
impacts
Personal Adjustment and Role Skills
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Abi Daoud, Dooley
et al. [16]
Parents with a son with DMD were more likely to have
an episode of major depression and to have consulted
a mental health professional during the last year, and to
demonstrate lower self- esteem, than parents in a control group.
Psychological
impacts
Depression Scale comprised of
items from the World Health
Organization's Composite
International Diagnostic Interview Short
Form (CIDI-SF)
42 parents from
26 families 27 males
with DMD
Canada
Chen [24] Parents of children who were diagnosed at an earlier age
reported an increase in ability to cope as a family. Child's
level of disability and family hardiness was not correlated
to level of family function.
Psychological
impacts
Family Hardiness Index, Family





Chen, Chen et al. [25] Parents with a child with DMD were more aggressive about
obtaining resources for their child, with higher stress levels
for mothers, and families with a lower income. Coping
strategies were used more often in mothers, but overall,
fewer coping strategies for emotional expression, self-blame,
information seeking, and threat minimization were made.
Psychological
impacts
Chronic Impact and Coping Instrument






Chen and Clark [27] Parents' employment and education, as well as perceived
child health and family hardiness/support, was correlated
with parental health. Promotion of family hardiness can be
supported by nursing interventions and caregiving programs.
Psychological
impacts





Most families reported a positive emotional impact from
the trial, with minimal negative impact. Families reported
having adequate knowledge and information about the
study. Some families reported negative impacts and




Parental Stress and Supports
Questionnaire (PSSQ), General Health






Chen and Clark [26] There were significant correlations between age at
diagnosis and family function, with better outcomes
associated with a younger age at diagnosis. As well,
the level of the child's disability was not associated
with family function. However, parents did report poorer
overall health and an increase in anxiety, depression, and
pain and disability, compared to the general population.
Psychological
impacts
Barthel Index, Chinese version of Duke
Health Profile 27, Family APGAR28,








Parsons, Clarke et al. [46] Prenatal screening for DMD was supported by most families,
however anxiety levels for the screened group was higher.
Psychological
impacts
Structured question developed by
authors, FIRST scores, State Scale,
General Health Questionnaire (GHQ)
20 families w/ child w/
DMD, 18 transient,




Cyrulnik, Fee et al. [28] By parental report, children with DMD demonstrated
significant delays in adaptive behaviour skills. Children




Vineland Adaptive Behavior Scales,




Fee, Hinton et al. [29] Children living with DMD demonstrated strong behavioural




Child Behavior Checklist (CBCL),
Parental Stress Index
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Firth, Gardnermedwin
et al. [30]
Parents reported problems in three main categories: service,
practical, and emotional. Parents were also in favour of
prenatal screening and early support, as well as an increase
in availability of information. Communication within the
family about the disease and implications was also reported






53 families of boys
with DMD
USA
Pangalila, van den Bos
et al. 2012 [44]
Parents reported that there was substantial burden as
caregivers to adults with DMD, specifically surrounding
received support, tracheotomy, active coping, and anxiety.
Illness
experiences
Caregiver Strain Index (CSI), Self Rated
Burden Scale, The EuroQoL-5D,
Hospital Anxiety and Depression Scale
(HADS), Utrecht Coping List (UCL).
General Self-Efficacy Scale





The adolescents interviewed did not identify themselves
through their diagnosis, and did not see their diagnosis as
a crisis. Spirituality and longing was explored as a means










Participants recognized that they themselves may lack
communication skills. The degree of rapport between









Steele, Taylor et al. 2008 [51] Half of the children have attention deficit–hyperactivity
disorder ADHD, which has not been reported in the
literature. In the area of internalizing disorders, none
of these patients met criteria for depression, either on




The Schedule for Affective Disorders
and Schizophrenia for School-Age
Children (KSADS), Revised Children’s
Manifest Anxiety Scale (RCMAS), Children’s
Depression Inventory (CDI), Piers-Harris
Children’s Self- Concept Scale, Wechsler
Intelligence Scale for Children: Third
Edition (WISC-III), KSADS-Parent Version,
Child Behavior Checklist (CBCL),
Conners’ Parent Rating Scale
10 boys with DMD
and their parents
Canada
Arias, Andrews et al. 2011 [18] Fewer than 1 in 5 families were familiar with the term
"palliative care", and less than a third had legal plans
or advanced directives in place.
Other, use of
palliative care
Structured questionnaire developed by






Acharya, Ackerman et al.
2005 [17]
Most physicians support diagnostic genetic testing of
high-risk children but are less supportive of expanding
newborn screening. Willingness to expand newborn
screening does not correlate with professional
characteristics but rather with personal interest in
testing of their own children.
Other, attitudes
of staff
Survey developed by authors 600 paediatricians USA
Parker, Robb et al. 2005 [45] While adult patients with DMD deal with a progressive
physical impairment due to respiratory, orthopaedic,
and other medical factors, areas of disability with
often overlooked importance were found in areas
of social and medical support.





















Table 4 Summary of the findings of publications on non-medical impacts of DMD (Continued)
Kinali, Manzur et al. 2006 [40] The survey on the attitudes and practices of UK physicians
demonstrated that physicians accept and implement NIV
to DMD patients. As well most physicians reported that
they promoted shared decision making with DMD
patients with respect to NIV. There was also a lack in




Modified version of a previously
published questionnaire
59 physicians Canada, UK
Vandervelde, Van den Bergh
et al. 2009 [54]
The ACTIVLIM questionnaire showed a good sensitivity
to change and could be useful in research settings to
characterize the disease course of NMD.
Other ACTIVLIM Questionnaire 132 patients
with NMD
Belgium
Jutai, Rigby et al. 2000 [37] Our research provides good evidence to support the
claim that EADLs (Electronic Aids to Daily Living)
contribute significantly to the user's perceived functional
independence. Moreover, EADLs appear to enhance
other important aspects of the user's psychological





Psychosocial Impact of Assistive
Devices Scale (PIADS)
20 users of EADLs
and 21 non-users
Canada
Jarvinen, Lehesjoki et al.
2000 [36]
Carrier testing was in most cases correctly understood and
the matter openly discussed. Our results do not suggest
that testing in childhood had caused serious harm to
the young individuals tested. On the other hand, we
found no obvious benefits from this early testing.
Other Questionnaire developed by authors,
RAND 36-item Health Survey 1.0





Kemper and Wake 2007 [38] Evidence for routine newborn screening for DMD was
reviewed, without sufficient data to make a strong
recommendation. Further research in the areas of cost,























Table 5 Summary of findings of publications on non-medical impacts of osteogenesis imperfecta
Publication Major findings Domain Instruments used Sample (N) Country
Balkefors, Mattsson et al. [55] Life satisfaction was high even though health-related quality of life, assessed
with the Short Form 36, was significantly lower than the Swedish norm.
QOL SF-36 29 adults Sweden
Kok, Uiterwaal et al. [61] We found little difference in quality of life between the bisphosphonate and
placebo groups however in favour of the bisphosphonate group during the
two-year follow-up.
QOL Database review 54 children
with OI
Netherlands
Seikaly, Kopanati et al.
2005 [63]
These studies showed a correlation between the severity of the phenotypic
expression of OI and QOL indicators tested. Reduced pain, besides being
by itself an advantageous outcome, allows effective physical therapy and
weight bearing, both benefits that help further strengthen bone. We
speculate that improvement in pain resulted in a better sense of
well- being and subsequently better self-care scores.







Kurnatowska et al. 2012 [65]
The child’s disease did not significantly affect either the global quality of
life assessment or health of the respondents or their quality of life in
terms of physical and psychological status and social relationships. The
parents of children with severe OI assessed the life domain associated
with the environment they live in as worse than the parents of children
with mild OI. The global quality of life assessment of the respondents
did not depend on the family’s socioeconomic status or on the help
they have been receiving with regard to care for the child.
QOL WHOQOL-BREF, International Standard
Classification of Education (ISCED),





Widmann, Laplaza et al.
2002 [68]
The results of the SF-36 revealed significantly lower physical function
scores compared to the U.S. adult norms. However, the SF-36 mental
component scores were equal to the U.S. adult norms. The demographic
questionnaire revealed high levels of educational achievement, as well as
employment, despite significant physical impairments. The functional
questionnaire clearly demonstrated limitations mostly related to ambulation.





Widmann, Bitan et al.
1999 [69]
Physical health as assessed by the SF-36 was closely correlated with
vital capacity and scoliosis. Mental health status (assessed by the
SF-36 MCS) was not significantly correlated with spinal deformity, chest
wall deformity, or pulmonary compromise.





Cole 1993 [58] Psychological aspects studied in a chronologic manner. Impacts on
parents, patients, siblings mentioned. Challenges at school, in the




N/A – Opinion paper Canada
Suskauer, Cintas et al.
2003 [64]
The data suggest that children with OI differ only to the extent that
they are relatively hypoactive, and the temperament domains of
activity, persistence, and first reaction (approach/withdrawal) may
be particularly important for promoting motor achievement.
Psychological
impacts
Carey Temperament Scales, Brief
Assessment of Motor Function (BAMF),
VCOPS, CHAQ, PDH, Pediatric Activity
Record (PAR)
35 children w/




Families with children with BBD face many difficulties such as
accusations of child abuse, lack of support, and lack of information
on the disease. Family activities and family




Questionnaire developed by authors,
based on their previous studies,





Brodin 1993 [57] For children growing up with brittle bones and their families the
living conditions are sometimes complicated as they cannot
participate in social life together with other young people. Parents of
Illness
experience
























Table 5 Summary of findings of publications on non-medical impacts of osteogenesis imperfecta (Continued)
disabled children often complain that their anxieties have been ignored
by professionals. No one seems to take them seriously. They have little
psychological support and many parents need merely a person to talk to.
In order to facilitate habilitation of the child, support should be given
to the whole family.
Daly, Wisbeach et al.
1996 [59]
The prognosis for walking in OI was assessed by questionnaire, finding
five different patterns of development: abnormal/arrested, delayed/arrested,
delayed, and normal. The Sillence and Shapiro classifications were useful
in predicting walking. Intramedullary rodding was not advised if the
patients had a delay solely in motor development.
Functional
limitations




Engelbert, Uiterwaal et al.
2000 [60]
As a predictor of ability to walk in a household, type of OI is the best,
along with severity of the collagen defect, and the presence of
dentinogenesis imperfecta. Intramedullary rods in the lower
extremities have a worse prognosis for walking.
Functional
limitations
Questionnaire developed by authors 76 children
with OI
Netherlands
Montpetit, Dahan-Oliel et al.
2011 [61]
Young adults with OI type III had significantly lower activity scores in
aspects of mobility and domestic life and lower levels of participation
in employment, sporting activities and transportation. Participation in
leisure and social interactions were not different across OI types.
Functional
limitations
Modified questionnaire including scales
of the Functional Independence Measure





Van Brussel, Takken et al.
2008 [67]
A supervised training program can improve aerobic capacity and muscle
force and reduces levels of subjective fatigue in children with OI type I




Checklist Individual Strength-20 (CIS-20),
Self-perception Profile for Children (CBSK),





Tolboom, Cats et al. 2004 [66] The present study demonstrated a non-significant, but clinically important
increase in self-care with a decrease in caregiver assistance regarding




Harter Self-Perception Profile for Children
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den of care on families.
From the limited number of publications on the im-
pacts of DMD, achondroplasia and OI, we have learned
that research about non-medical impacts of achondro-
plasia, DMD and OI on healthcare systems and society
seems very limited and could be further addressed. How-
ever, the selection of the keywords used in the searching
strategy in this review might have resulted in the exclu-
sion of some publications. For example, challenges in
providing adequate updating training to clinicians and
staff on these rare diseases as acknowledged in other
RGDs could be examined. In addition, research on
healthcare-related impacts might compare the use of
healthcare resources according to the severity of the dis-
ease. Efficient care delivery models organised around
primary care whereby family physicians can help to
achieve a smooth transition to adult care institutions
must also be investigated [56,77,78]. In addition more
theoretical understanding is needed about the complex
and non-linear interrelationships between two aspects of
QOL: the available quality of care and the family function-
ing and economic status [79-81]. Such understanding will
help to acknowledge the relative impacts of these determi-
nants on overall QOL and will help to prioritize adequate
interventions.
We acknowledge that methodological limitations could
have compromised the inclusion of publications reviewed
here. Thus, further longitudinal studies combining norma-
tive approaches with qualitative in-depth investigations
and comparing several diseases could enhance the under-
standing of patients’ effective coping strategies. Simultan-
eous use of parent-report and patient-report questionnaires
could provide increased insights [22]. Furthermore, our in-
house working framework that guided our organization
and analysis of the scoping review could aid others in map-
ping and organizing the literature during a scoping review;
however, to extend its use beyond this would require fur-
ther validation.
Conclusion
In general, DMD and OI negatively impacted carers. Some
events seem particularly critical such as occurrence of
fractures or loss of ambulation in patients. As for patients,
functional limitations seemed to follow the severity of the
disease, but psychological distress did not, which calls for
a better understanding of effective coping strategies. This
conclusion is supported by the reported higher life satis-
faction in very severely affected patients at different stages
of the progressing course of DMD, and the reported resili-
ence characteristic of adolescents with OI. In face of the
great difficulties presented to families, life span and
family-centered psychological support must be developed
in a timely fashion to aid patients, carers, and siblings.Abbreviations
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